Black patients with cancer are significantly more likely to experience cardiotoxicity and congestive heart failure related to chemotherapy than White cancer patients are, a research review indicates. ...

Future Cardiol. 2012;8(4):647-670. Although redox-induced damage is likely involved in anthracycline-induced cardiotoxicity, some evidence suggests that it is not the only mechanism at play. Several ...

Please provide your email address to receive an email when new articles are posted on . Black race was associated with 71% greater odds of chemotherapy-related cardiotoxicity vs. white or non-Black ...

Please provide your email address to receive an email when new articles are posted on . A decrease in left ventricular ejection fraction to below normal levels occurred more frequently among women ...

Radiation and chemotherapy for Hodgkin's lymphoma can lead to late-onset cardiotoxicity, including coronary artery disease. Self-advocacy and detailed medical history are crucial for timely diagnosis ...

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human ...

Scholastic Achievements of Childhood Leukemia Patients: A Nationwide, Register-Based Study The design and efficacy of the major adjuvant trastuzumab trials was assessed, including the National ...

CHICAGO -- Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving anthracycline chemotherapy in the SARAH trial. Cancer patients were less likely ...

Trastuzumab-mediated cardiotoxicity was originally described in women with metastatic breast cancer. The incidence rates were 13% when the antibody was administered in combination with paclitaxel and ...

Primary cultures of spontaneously beating myocardial cells isolated from neonatal rat hearts were used to screen the cardiotoxic effects of Jamesoni's mamba (Dendroaspis jamesoni) venom and components ...